Astera Labs, Inc. (ALAB) designs connectivity semiconductors — PCIe and CXL retimers, smart cable modules, fabric switches and memory controllers — that move data between accelerators inside AI data centers. Shares were trading at $211.50 in Monday's session, a decline of 4.66% from the prior close of $221.83. The stock opened at $208.04, touched $201.00, and has since pared part of the loss. The move is a sector-driven drawdown rather than a reaction to fresh company news: the optics and AI-interconnect complex sold off broadly as investors trimmed exposure ahead of Nvidia's earnings and Anthropic's market debut.
Nvidia reports fiscal third-quarter results after the close on Tuesday, the first such report since Jensen Huang stepped down as chief executive and director on November 12. Nvidia has now posted its longest weekly losing streak since October 2012, and reports that Huang is weighing a return have added to uncertainty rather than resolved it. Because Astera Labs' revenue is tied directly to the pace of accelerator deployment — its Scorpio fabric switches ramp alongside hyperscaler GPU clusters — the stock trades as a high-beta proxy on Nvidia's forward outlook. Investors reduced exposure across the supply chain rather than waiting for the print.
Last week's hotter-than-expected inflation data left the market fully priced for a December rate increase, with a small probability assigned to a 50-basis-point move. Higher financing costs hit two ways: they compress the valuation multiples applied to high-growth semiconductor names, and they raise questions about the borrowing economics behind AI data center buildouts. Astera Labs still trades at roughly 20 times trailing sales on a market value near $38 billion, leaving it sensitive to discount-rate shifts.
Anthropic is expected to price and begin trading this week, marketing 825 million shares at $70–$78 for a valuation in the $1.3–$1.4 trillion range. The deal is heavily oversubscribed, and strategists note that investors funding the allocation may sell existing AI holdings to make room. That dynamic creates mechanical supply in exactly the names Astera Labs competes with for AI portfolio dollars, and a successful debut does not guarantee sympathy buying in incumbent AI hardware.
Astera Labs beat on the third quarter, with revenue of $584.9 million, up 154% year over year, adjusted EPS of $1.32 and a fourth-quarter guide of $730–$750 million against roughly $656 million consensus. The market nonetheless focused on a flatter gross margin near 72%, a step-up in operating expenses to $194–$200 million next quarter, and heavy concentration in a single lead hyperscaler for Scorpio X-Series. Target cuts followed from Needham ($425 to $300), Evercore ($452 to $311), UBS (to $290, Neutral), Susquehanna ($310 to $258), TD Cowen ($300 to $225, Hold) and RBC ($500 to $400). The consensus rating remains Buy, but the estimate revisions explain why rallies have been sold.
Turnover was elevated, running at roughly three times the normal pace against a 20-day average near 2.7 million shares. The decline was consistent with peers and worse than the indices: Credo fell 6.7%, Marvell 5.2% and Coherent 5.4%, while the semiconductor ETF slipped 2.8% and the Nasdaq 100 1.2%; Nvidia itself was nearly flat, highlighting how sharply the interconnect sub-sector underperformed the AI bellwether. Technically, the stock remains well below its 20-day average near $247 and its 50-day average near $294, extending a downtrend from June's high above $483. The intraday recovery off $201 suggests buyers appeared near the November 6 area, but the $222 level that capped Friday's session now reads as near-term resistance.
The scale runs from 0, meaning no meaningful news and a move that is ordinary for the stock, to 100, meaning transformative news and an extreme, rare price move. Astera Labs scores 16 out of 100. No new company-specific disclosure drove Monday's decline; the catalysts were sector and macro in nature, and materiality relative to a $38 billion company is modest. The price move was also unremarkable by this stock's standards: at 4.66%, it was only about 1.0 times the typical 4.6% absolute daily swing, and moves of similar or greater size occurred 19 times in the last 60 sessions. Weak news and a routine move combine into a low score.
Nvidia's report and, more importantly, its data center guidance will set the tone for the group into year-end. Anthropic's pricing and first-day trading will test whether capital is rotating into new AI listings or away from the sector entirely. Domestically, the FOMC minutes on Wednesday and commentary from Fed officials will sharpen rate expectations, while retail sales data will inform the growth outlook. Astera Labs' own next fundamental checkpoint is its fourth-quarter report, expected in February 2027, when revenue against the $730–$750 million guide and gross margin trends will be scrutinized. Key risks include customer concentration, the timing of the transition to UALink and next-generation protocols, and the possibility that hyperscalers pause current-generation PCIe builds ahead of that shift.
Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, and the Trending AI Robots page curates only those models performing strongest under present market conditions. Bots differ widely by strategy, timeframe, performance metrics and the specific symbols they trade, so the page offers a useful way to see which approaches are currently keeping pace with a volatile tape like this one. Reviewing the live rankings is a practical next step for traders refining their own process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ALAB advanced for three days, in 148 of 167 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALAB's RSI Oscillator exited the oversold zone, 12 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 23 of 28 cases where ALAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ALAB just turned positive on November 13, 2026. Looking at past instances where ALAB's MACD turned positive, the stock continued to rise in 26 of 30 cases over the following month. The odds of a continued upward trend are 87%.
ALAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
ALAB moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALAB crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for ALAB entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. ALAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALAB's P/B Ratio (19.172) is very high in comparison to the industry average of (5.443). P/E Ratio (87.885) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (40.650) is also within normal values, averaging (46.468).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors